POST Online Media Lite Edition


Jay S. Duker joins pSivida board

Staff Writer |
Watertown, Mass., USA - September 28, 2016, Watertown, Mass., USA - pSivida Corp., a biotechnology company, announced the appointment of Jay S. Duker to the company’s board of directors.

Article continues below

Dr. Duker is the Director of the New England Eye Center and Professor and Chairman of Ophthalmology at the Tufts Medical Center and the Tufts University School of Medicine.

Dr. Duker serves on the editorial board of three ophthalmic journals.

Dr. Duker is also a director of Eleven Biotherapeutics, a biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye.

He is a co-founder and Director of Hemera Biosciences, a privately held company seeking to develop anti-complement gene based therapies for the treatment of dry and wet age related macular degeneration.

LATEST 5 MOVES FROM Massachusetts 

What to read next

pSivida names Nancy Lurker as president, CEO and board member
X4 Pharmaceuticals names Nancy Lurker as chair of board
Keryx Biopharmaceuticals appoints two directors